CN103599137A - Health food containing plurality of trace nutrient elements - Google Patents
Health food containing plurality of trace nutrient elements Download PDFInfo
- Publication number
- CN103599137A CN103599137A CN201310357259.7A CN201310357259A CN103599137A CN 103599137 A CN103599137 A CN 103599137A CN 201310357259 A CN201310357259 A CN 201310357259A CN 103599137 A CN103599137 A CN 103599137A
- Authority
- CN
- China
- Prior art keywords
- grams
- content
- gram
- vitamin
- dimension
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 20
- 235000013402 health food Nutrition 0.000 title abstract description 3
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 16
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000011575 calcium Substances 0.000 claims abstract description 15
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 15
- 235000011649 selenium Nutrition 0.000 claims abstract description 15
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 15
- 239000011669 selenium Substances 0.000 claims abstract description 15
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000013793 astaxanthin Nutrition 0.000 claims abstract description 14
- 235000012661 lycopene Nutrition 0.000 claims abstract description 12
- 235000021283 resveratrol Nutrition 0.000 claims abstract description 12
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims abstract description 11
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 9
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 9
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 9
- 239000011710 vitamin D Substances 0.000 claims abstract description 9
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 9
- 229940046008 vitamin d Drugs 0.000 claims abstract description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 8
- 229960000304 folic acid Drugs 0.000 claims abstract description 8
- 235000019152 folic acid Nutrition 0.000 claims abstract description 8
- 239000011724 folic acid Substances 0.000 claims abstract description 8
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 8
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 8
- 239000011719 vitamin A Substances 0.000 claims abstract description 8
- 229940045997 vitamin a Drugs 0.000 claims abstract description 8
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 6
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 5
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 5
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 5
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 4
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 4
- 229960003495 thiamine Drugs 0.000 claims abstract description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 4
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 4
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 4
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 4
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 4
- 229960002685 biotin Drugs 0.000 claims abstract description 3
- 235000020958 biotin Nutrition 0.000 claims abstract description 3
- 239000011616 biotin Substances 0.000 claims abstract description 3
- 230000036541 health Effects 0.000 claims description 28
- 239000003094 microcapsule Substances 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 18
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 14
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- 229920002414 procyanidin Polymers 0.000 claims description 14
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims description 10
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims description 10
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims description 10
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 10
- 235000010930 zeaxanthin Nutrition 0.000 claims description 10
- 239000001775 zeaxanthin Substances 0.000 claims description 10
- 229940043269 zeaxanthin Drugs 0.000 claims description 10
- 239000011785 micronutrient Substances 0.000 claims description 8
- 235000013369 micronutrients Nutrition 0.000 claims description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 7
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 7
- 150000001514 astaxanthins Chemical class 0.000 claims description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
- 229940046374 chromium picolinate Drugs 0.000 claims description 7
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 claims description 7
- 229910021446 cobalt carbonate Inorganic materials 0.000 claims description 7
- ZOTKGJBKKKVBJZ-UHFFFAOYSA-L cobalt(2+);carbonate Chemical compound [Co+2].[O-]C([O-])=O ZOTKGJBKKKVBJZ-UHFFFAOYSA-L 0.000 claims description 7
- 150000002664 lycopenes Chemical class 0.000 claims description 7
- 239000000395 magnesium oxide Substances 0.000 claims description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 7
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 7
- 235000006748 manganese carbonate Nutrition 0.000 claims description 7
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical class [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 239000011684 sodium molybdate Substances 0.000 claims description 7
- 235000015393 sodium molybdate Nutrition 0.000 claims description 7
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 claims description 7
- SRFKWQSWMOPVQK-UHFFFAOYSA-K sodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate;iron(2+) Chemical compound [Na+].[Fe+2].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SRFKWQSWMOPVQK-UHFFFAOYSA-K 0.000 claims description 7
- 239000011576 zinc lactate Substances 0.000 claims description 7
- 229940050168 zinc lactate Drugs 0.000 claims description 7
- 235000000193 zinc lactate Nutrition 0.000 claims description 7
- 201000010099 disease Diseases 0.000 abstract description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 239000000126 substance Substances 0.000 abstract description 13
- 239000002775 capsule Substances 0.000 abstract description 12
- 235000013305 food Nutrition 0.000 abstract description 8
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 abstract description 7
- 239000001168 astaxanthin Substances 0.000 abstract description 7
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 abstract description 7
- 229940022405 astaxanthin Drugs 0.000 abstract description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 abstract description 5
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 abstract description 5
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 abstract description 5
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 abstract description 5
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 abstract description 5
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 abstract description 5
- 239000001751 lycopene Substances 0.000 abstract description 5
- 229960004999 lycopene Drugs 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 5
- 229940016667 resveratrol Drugs 0.000 abstract description 5
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 4
- 229930003231 vitamin Natural products 0.000 abstract description 4
- 235000013343 vitamin Nutrition 0.000 abstract description 4
- 239000011782 vitamin Substances 0.000 abstract description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 3
- 229930003268 Vitamin C Natural products 0.000 abstract description 3
- 229930003427 Vitamin E Natural products 0.000 abstract description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003963 antioxidant agent Substances 0.000 abstract description 3
- 230000003078 antioxidant effect Effects 0.000 abstract description 3
- 235000006708 antioxidants Nutrition 0.000 abstract description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 3
- 235000019154 vitamin C Nutrition 0.000 abstract description 3
- 239000011718 vitamin C Substances 0.000 abstract description 3
- 235000019165 vitamin E Nutrition 0.000 abstract description 3
- 239000011709 vitamin E Substances 0.000 abstract description 3
- 229940046009 vitamin E Drugs 0.000 abstract description 3
- 239000011701 zinc Substances 0.000 abstract description 3
- 229910052725 zinc Inorganic materials 0.000 abstract description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract description 2
- 229930003471 Vitamin B2 Natural products 0.000 abstract description 2
- 229910052804 chromium Inorganic materials 0.000 abstract description 2
- 239000011651 chromium Substances 0.000 abstract description 2
- 235000012721 chromium Nutrition 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 235000005911 diet Nutrition 0.000 abstract description 2
- 230000037213 diet Effects 0.000 abstract description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract description 2
- -1 procyanidine Chemical compound 0.000 abstract description 2
- 229960002477 riboflavin Drugs 0.000 abstract description 2
- 235000019164 vitamin B2 Nutrition 0.000 abstract description 2
- 239000011716 vitamin B2 Substances 0.000 abstract description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 abstract 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 abstract 1
- 239000010941 cobalt Substances 0.000 abstract 1
- 229910017052 cobalt Inorganic materials 0.000 abstract 1
- 235000013495 cobalt Nutrition 0.000 abstract 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 abstract 1
- 239000010949 copper Substances 0.000 abstract 1
- 229910052802 copper Inorganic materials 0.000 abstract 1
- 235000021321 essential mineral Nutrition 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 229910052750 molybdenum Inorganic materials 0.000 abstract 1
- 239000011733 molybdenum Substances 0.000 abstract 1
- 235000016768 molybdenum Nutrition 0.000 abstract 1
- 229940055726 pantothenic acid Drugs 0.000 abstract 1
- 239000011713 pantothenic acid Substances 0.000 abstract 1
- 230000001766 physiological effect Effects 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 235000008210 xanthophylls Nutrition 0.000 abstract 1
- 150000003735 xanthophylls Chemical class 0.000 abstract 1
- JKQXZKUSFCKOGQ-QAYBQHTQSA-N zeaxanthin Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-QAYBQHTQSA-N 0.000 abstract 1
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 13
- 150000003254 radicals Chemical class 0.000 description 13
- 102000004877 Insulin Human genes 0.000 description 9
- 108090001061 Insulin Proteins 0.000 description 9
- 229940125396 insulin Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 7
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000470 constituent Substances 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 208000001132 Osteoporosis Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 210000004153 islets of langerhan Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 231100000915 pathological change Toxicity 0.000 description 4
- 230000036285 pathological change Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 239000002366 mineral element Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000011321 prophylaxis Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 208000002177 Cataract Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010019663 Hepatic failure Diseases 0.000 description 2
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 231100000481 chemical toxicant Toxicity 0.000 description 2
- 230000001447 compensatory effect Effects 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 2
- 201000008980 hyperinsulinism Diseases 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000007903 liver failure Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 230000009978 visual deterioration Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 208000035719 Maculopathy Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 102000007501 Thymosin Human genes 0.000 description 1
- 108010046075 Thymosin Proteins 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000863032 Trieres Species 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004705 lumbosacral region Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 208000019180 nutritional disease Diseases 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention provides a healthcare food containing a plurality of trace nutrient elements, and belongs to the technical field of trace nutrient element healthcare food. The healthcare food is composed of twenty eight kinds of materials, namely calcium, magnesium, zinc, iron, selenium, manganese, copper, chromium, cobalt, molybdenum, vitamin A, vitamin C, vitamin E, vitamin D, vitamin B1, vitamin B2, vitamin B6, vitamin B12, nicotinamide, pantothenic acid, biotin, folic acid, resveratrol, procyanidine, astaxanthin, lycopene, xanthophylls, and zeaxanthine. The healthcare food organically compounds a plurality of essential mineral substances, vitamins, and antioxidant plant extracts together and presses the materials into tables or capsules. The elements in the healthcare food cooperates with each other to generate a balanced and synergetic effect; the supply amount of biological elements is sufficient; the element ratio is balanced and harmonious, is totally in a safe range of diet recommended amount provided by Chinese Nutrition Society, and the health food provides an enough amount of nutrient elements for body physiological activities and body functions of preventing diseases and removing toxicity on the basis of safety.
Description
Technical field
The present invention relates to one kind of multiple micronutrient element health product, belong to trace element health-care product technical field.
Background technology
Vitamin, mineral are to maintain the indispensable nutrient substance of human life, safeguarding aspect health, defying age, prevent disease, play irreplaceable effect, the extraction of anioxidant phytochemicals and application, for the mankind's health has played positive facilitation.Along with the raising of people's living standard and the change of diet structure, and the raising of foods processing technique, making to maintain dirt life healthy various dimension dirt elements and mineral element quantity in food reduces, with protein, fat, the high intake of saccharide homenergic material is compared, it is obviously not enough that its quantity seems, cause nutrient to take in serious uneven, and these energy matters of metabolism, need the participation of vitamin and the mineral of sufficient amount, in health, the activity of most of enzymes needs these nutrients to activate, in addition, along with going from bad to worse of environment for human survival, air, the pollution of water source and food, and bad dirt the forming of being accustomed to alive of people, such as smoking, excessive drinking, stay up late, long-time online etc., health just needs more dimension dirt element and mineral help human body to remove to get rid of the metabolism rubbish of chemical toxicant in body and free radical and so on like this, this just makes the micro-element nutrition material of Deficiency of Intake originally seem more not enough, and long-term deficiency or the relative deficiency of vitamin and mineral element intake, can cause the imbalance of energy i (in vivo) substance metabolism, toxin can not be got rid of completely, the excessive accumulation that causes body fat, blood glucose and blood fat raise, immunity of organisms reduces, physical function is degenerated, finally caused the generation with the closely-related various diseases of nutrient imbalance, as: hypertension, hyperlipidemia, obesity, diabetes, arteriosclerosis, cardiovascular and cerebrovascular disease, cancer, fatty liver, osteoporosis etc., the mankind's health in these disease serious threats, affect more and more rich people's dirt bioplasm amount.Existing its nutrient substance of multivitamin product is comprehensive not enough, and ratio is coordinated not enough, is difficult to meet the demand that people are higher.
Summary of the invention
The object of the invention is the problem existing in order to solve above-mentioned prior art, existing its nutrient substance of multivitamin product is comprehensive not enough, and ratio is coordinated not enough, is difficult to meet the demand that people are higher.And then provide one kind of multiple micronutrient element health product.
The object of the invention is to be achieved through the following technical solutions:
One kind of multiple micronutrient element health product, by weight by 200～500 grams of calcium carbonate; 100～200 grams of magnesium oxide; 15～30 grams of zinc lactate; 10～20 grams of sodium iron ethylenediaminetetraacetate; 0.5～2 gram of curpic carbonate; 3～8 grams of manganese carbonates; 0.5～2 gram of chromium picolinate; 0.2% 40～80 grams of content selenium yeast; 0.1～0.5 gram of sodium molybdate; 0.05～0.2 gram of cobalt carbonate; 50% 3～6 grams of content dimension dirt element A microcapsule powders; 15～40 grams of sodium ascorbaties; 50% 2～10 grams, content Vitamin E contained micro capsule powder; 0.25% 1～5 gram of content vitamin D microcapsule powder; Vitamin B1: 1.5～5 grams; Dimension dirt element B2:1.5～5 gram; Vitamin B6: 1.5～5 grams; Dimension dirt element B12:0.03～0.2 gram; 1.5～5 grams of nicotiamide; 1.5～5 grams of calcium pantothenates; 3～10 grams of dirt thing elements; 0.1～0.5 gram, folic acid; 50% 50～200 grams of content resveratrols; 95% 50～200 grams of content procyanidins; 5% 50～200 grams of content astaxanthins; 20% 10～50 grams of content lycopenes; 20% 10～50 grams of content phylloxanthins and 2～10 grams of compositions of 10% content zeaxanthin.
The dirt production. art of capsule of the present invention: the abundant mix homogeneously of above-mentioned raw materials, fill is No. 0 capsule the inside, and about 0.6 gram of each capsule, can 1000～2500 capsules of fill.
The production technology of tablet of the present invention: the abundant mix homogeneously of above-mentioned raw materials, add appropriate cellulose and magnesium stearate, use tablet machine tabletting, about 0.7 gram of each tablet, can tabletting 1000～2500.
Instructions of taking: take 2～4 capsules or tablet every day; Being applicable to 18 years old above adult takes; Applicable crowd: the treatment of Disease recovering aid, healthy population daily health caring.
Points for attention: hepatic and kidney function obstacle person be cautious use of; Liver and kidney failure patient forbidding; Whether patient with severe symptoms can take is asked Ref Dr.
The present invention is organically combined with each other the necessary several mineral materials of human body with dimension dirt element and various plants antioxidant extract, be pressed into tablet or make capsule, make mutual balance between element, cooperatively interact, interact, bring out the best in each other, dirt life element supply is sufficient, between element, quantitative proportion is balanced coordinates, and, within Chinese Soclety of Nutrition's meals recommended amounts safety range, guaranteeing on safe basis completely, meeting the quantity of the needs of health physiology and disease-resistant, toxin expelling.The present invention not only can comprehensive enough equilibriums supplement the required multiple dirt life element of health, and, procyanidin, astaxanthin, resveratrol, lycopene, the use in conjunction of the natural plants such as phylloxanthin and zeaxanthin polyphenoils, more given product outstanding getting rid of illness, diseases prevention, the effect of body-building, can effectively prevent the generation of the various diseases that causes because of the damage of nutrient imbalance and oxyradical, comprise: hypertension, hyperglycemia, hyperlipidemia, sclerosis of blood vessels, cardiovascular and cerebrovascular disease, obesity, various cancers, viral infection, rheumatism atrophic arthritis, hypoimmunity, osteoporosis, hepatitis, liver cirrhosis, visual deterioration, cataract, the blind generation that waits various diseases that optical fundus maculopathy causes.
The mechanism of action of the present invention is as follows: hypertension is because sclerosis of blood vessels, the recrementitious blood vessel accesses of blood such as blood vessel deposition blood fat and cholesterol narrow down and send out the pathological changes of dirt, reduce the viscosity of blood, reduce blood fat and blood cholesterol levels, strengthen the elasticity of blood vessel, the just fundamentally generation of prophylaxis of hypertension, the Multiple components of the present invention the inside is such as resveratrol, procyanidin, lycopene, astaxanthin, selenium element, dimension dirt element C, zinc element etc., have and promote the synthetic of collagen protein, improve blood vessel elasticity, reduce blood fat and cholesterol levels, dilute blood, remove the effect of blood and blood vessel wall rubbish, therefore prophylaxis of hypertension effectively, hyperlipidemia, arteriosclerosis, the generation of the diseases such as cardiovascular and cerebrovascular disease, due to multiple dimension dirt element and mineral element interaction, safeguarded the homergy function of fat and sugar and protein, make regulation of fat in body in normal level, thus generation that can prevent obesity, onset diabetes reason is a lot, there are inherited genetic factors, environmental factors, emotional factor, trophic factor etc., because insulin is processed the blood sugar increasing that the function generation obstacle of blood glucose causes at first, also be insulin resistant, the islets of langerhans that is flooded with higher concentration that causes compensatory in blood is balance blood sugar usually, in blood, the insulin of high-load can cause hyperinsulinemia, this can bring a series of danger, and hyperinsulinemia is the common pathogenesis basis such as coronary heart disease, hypertension, hyperlipidemia, type ii diabetes, obesity, apoplexy.Studies confirm that, insulin resistant and the glucose carbohydrate tolerance factor are associated extremely, also suffer free radical attack damage relevant with health islet cells, the former can reduce insulin efficiency, the latter can affect islet cells and secrete healthy insulin, chromium element in the present invention is the constituent of glucose tolerance factor, human body lacks chromium element for a long time, can cause glucose tolerance factor to send out dirt abnormal, insulin is processed the Efficiency Decreasing of blood glucose, therefore supplement the work efficiency that appropriate chromium element can improve insulin, in addition, selenium element wherein, vitamin A, dimension dirt element C, dimension dirt element E, procyanidin, resveratrol, the compositions such as astaxanthin, the over oxidation that can effectively stop health, remove the free radical in body, can effectively protect islet cells to avoid radical damage, thereby can protect pancreas organ normally to secrete the function of healthy insulin, fundamentally prevent diabetes sends out dirt, anticancer mechanism of the present invention: modern medicine confirms, cancer send out dirt, suffer the attack of free radical to cause DNA damage closely related with body, the attack, the protection DNA that therefore protect soma to avoid free radical avoid damage, generation that just can prophylaxis of cancer.The harmful substance that the generation of free radical enters with health is relevant, also relevant with bad living habit, therefore, harmful substance in body is excreted in time to the generation that just can effectively prevent free radical, even if formed free radical, before cell and DNA not being caused damage, these free radical scavengings are external, can not cause substantial injury to bodily tissue yet, the selenium element of the present invention the inside, the nutrient substance such as dimension dirt element C, the ability that has excellent eliminating chemical toxicant, they can be combined with the harmful chemical that enters human body or be reduced into insoluble, or being reduced into harmless compound excretes, in addition, they also have the function of outstanding removing free radical, because selenium element is the important composition composition of glutathione peroxidase, this is the free radical scavenger that a kind of performance is powerful, selenium element can be worked in coordination with vitamin C, dimension dirt element E, lycopene, procyanidin, the antioxidant such as astaxanthin complete the task of removing interior free yl jointly, Cell protection is complete, DNA is injury-free in protection, fundamentally prevent the generation because of the cancer of genovariation initiation, viral infection declines relevant with rheumatism atrophic arthritis with health immune function, medical experiment confirms, selenium, zinc, ferrum, manganese, vitamin A, C, E, procyanidin, resveratrol, astaxanthin, the nutrient substance such as lycopene can improve immune function of human body, the raising of immune function comprises the raising of cellular immunization and humoral immunization function, improve the phagocytic activity of macrophage, the growing amount of lymphocyte and neutrophil cell can roll up, increase the secretion of thymosin and interleukin, thereby effectively prevent each viroid and the invasion of antibacterial and the dirt of inflammation to become, can prevent various viral infection and virus type influenza, the inflammation at each position of Control and prevention whole body etc., osteoporosis belongs to the compensatory disease that calcium loss causes, with advancing age, the absorption of calcium constituent reduces gradually, in order to maintain the normal concentration of calcium constituent in blood, will constantly consume the calcium constituent storing in skeleton, skeletal calcium element is reduced, finally caused osteoporosis, osteoporosis is very harmful to old people, can greatly increase the danger of fracture, the present invention contains abundant calcium constituent, manganese element, vitamin D, vitamin C, the nutrient substance such as procyanidin, not only directly supplemented calcium nutrition, can increase the deposition at skeleton of calcium constituent, promote the synthetic of bone collagen, increase skeleton density and intensity, fundamentally prevent because of osteoporotic generation, reduced the danger of fracture, visual deterioration, cataract, the pathological changes of optical fundus macular area is middle-aged and elderly people common disease, having a strong impact on old people's quality of life, its cause of disease is not only relevant with free radical infringement, also lack relevant with eye nutrient substance, such as phylloxanthin and zeaxanthin are the important component parts that forms optical fundus macula lutea, free radical is attacked part tissue of eye, and two kinds of nutrient Deficiency of Intake, the pathological changes that can cause optical fundus macular area, cause blurred vision, severe patient causes blind, the selenium being rich in the present invention, chromium, vitamin A, procyanidin, astaxanthin, phylloxanthin, the nutrient substance such as zeaxanthin, it is the effective ingredient of nutrition and protection eye health, not only can directly supplement the needed nutrient substance of eyes, can also prevent the pathological changes of the eye tissue that causes because of radical damage, eyes are played to real protective effect.The present invention is on probation the men and women volunteer of 30 years old～85 years old all ages and classes section through 20 multidigit ages, obtained very satisfied effect, the case relating to comprises: hypertension, hypotension, the dizzy headache that cerebral blood supply insufficiency causes, diabetes, blurred vision, constipation, insomnia, malaise, skin ultraviolet is irritated, what myocardial ischemia caused is uncomfortable in chest nervous, tracheitis, asthma, cancer postoperative rehabilitation, pain in the lumbar region, have a pain in the leg, foot pain etc., these patient's courses of disease the longest more than 10 years, the shortest some months, major part belongs to the patient of medication all the year round or intermittent use, take after health product of the present invention, effective the shortest 2～3 days, a general week is substantially effective, 12 days the slowest effective phases, obvious effective rate absolutely, according to most trier's reflections, reached the inaccessiable effect of basic medicine.The 70 percent above patient who participates in the experiment now original medicine used of having stopped using because be nutritional health food, to health without any side effect, user is very satisfied, and because the present invention does not belong to medicine, Healthy People can be taken throughout the year, can balancedly supplement needed by human body nutrient, the physiological function of General Promotion human body, improves immunity, resisting fatigue, defying age, antioxidation, prevents the generation of the multiple chronic disease relevant to nutritional disorder, thereby reaches the effect of illness prevention and fitness, life-saving.Health product of the present invention will greatly improve and improve health of people level and quality of life, effectively extend the mankind's life-span, can be torment and spiritual pressure that numerous patients palliate a disease, be expected to make some chronic diseases to reverse, to patient, bring the hope of rehabilitation, there is very important social benefit and good economic benefit.
The specific embodiment
Below the present invention is described in further detail: the present embodiment is implemented take technical solution of the present invention under prerequisite, provided detailed embodiment, but protection scope of the present invention is not limited to following embodiment.
One kind of multiple micronutrient element health product that the present embodiment is related, by weight by 200～500 grams of calcium carbonate; 100～200 grams of magnesium oxide; 15～30 grams of zinc lactate; 10～20 grams of sodium iron ethylenediaminetetraacetate; 0.5～2 gram of curpic carbonate; 3～8 grams of manganese carbonates; 0.5～2 gram of chromium picolinate; 0.2% 40～80 grams of content selenium yeast; 0.1～0.5 gram of sodium molybdate; 0.05～0.2 gram of cobalt carbonate; 50% 3～6 grams, content type vitamin A microcapsules powder; 15～40 grams of sodium ascorbaties; 50% 2～10 grams of content dimension dirt element E microcapsule powders; 0.25% 1～5 gram of content vitamin D microcapsule powder; Dimension dirt element B1:1.5～5 gram; Dimension dirt element B2:1.5～5 gram; Dimension dirt element B6:1.5～5 gram; Vitamin B12: 0.03～0.2 gram; 1.5～5 grams of nicotiamide; 1.5～5 grams of calcium pantothenates; 3～10 grams of biotin; 0.1～0.5 gram, folic acid; 50% 50～200 grams of content resveratrols; 98% 50～200 grams of content procyanidins; 5% 50～200 grams of content astaxanthins; 20% 10～50 grams of content lycopenes; 20% 10～50 grams of content phylloxanthins and 2～10 grams of compositions of 10% content zeaxanthin.
The dirt production. art of the present embodiment capsule: the abundant mix homogeneously of above-mentioned raw materials, fill is No. 0 capsule the inside, and about 0.6 gram of each capsule, can 1000～2500 capsules of fill.
The production technology of the present embodiment tablet: the abundant mix homogeneously of above-mentioned raw materials, add appropriate cellulose and magnesium stearate, use tablet machine tabletting, about 0.7 gram of each tablet, can tabletting 1000～2500.
Instructions of taking: take 2～4 capsules or tablet every day; Being applicable to 18 years old above adult takes; Applicable crowd: the treatment of Disease recovering aid, healthy population daily health caring.
Points for attention: hepatic and kidney function obstacle person be cautious use of; Liver and kidney failure patient forbidding; Whether patient with severe symptoms can take is asked Ref Dr.
One kind of multiple micronutrient element health product, preferably technical scheme is by weight by 210～490 grams of calcium carbonate; 110～190 grams of magnesium oxide; 16～29 grams of zinc lactate; 11～19 grams of sodium iron ethylenediaminetetraacetate; 0.6～1.9 gram of curpic carbonate; 4～7 grams of manganese carbonates; 0.6～1.9 gram of chromium picolinate; 0.2% 45～75 grams of content selenium yeast; 0.2～0.4 gram of sodium molybdate; 0.08～0.15 gram of cobalt carbonate; 50% 4～5 grams of content dimension dirt element A microcapsule powders; 20～35 grams of sodium ascorbaties; 50% 4～8 grams, content Vitamin E contained micro capsule powder; 0.25% 2～4 grams of content vitamin D microcapsule powders; Dimension dirt element B1:2～4 gram; Vitamin B2: 2～4 grams; Vitamin B6: 2～4 grams; Dimension dirt element B12:0.07～0.15 gram; 2～4 grams of nicotiamide; 2～4 grams of calcium pantothenates; 4～9 grams of dirt thing elements; 0.2～0.4 gram, folic acid; 50% 60～190 grams of content resveratrols; 98% 60～190 grams of content procyanidins; 5% 60～190 grams of content astaxanthins; 20% 20～40 grams of content lycopenes; 20% 20～40 grams of content phylloxanthins and 3～9 grams of compositions of 10% content zeaxanthin.
One kind of multiple micronutrient element health product, best technical scheme is by weight by 350 grams of calcium carbonate; 150 grams of magnesium oxide; 22 grams of zinc lactate; 15 grams of sodium iron ethylenediaminetetraacetate; 1.2 grams of curpic carbonate; 6 grams of manganese carbonates; 1 gram of chromium picolinate; 0.2% 60 grams of content selenium yeast; 0.3 gram of sodium molybdate; 0.1 gram of cobalt carbonate; 50% 4.5 grams of content type vitamin A microcapsules; 25 grams, dimension dirt element C sodium; 50% 6 grams of content dimension dirt element E microcapsules; 0.25% 3 grams of content vitamin D microcapsules; Dimension dirt element B1:3 gram; Dimension dirt element B2:3 gram; Vitamin B6: 3 grams; Dimension dirt element B12:0.11 gram; 3 grams of nicotiamide; 3 grams of calcium pantothenates; 7 grams of dirt thing elements; 0.3 gram, folic acid; 50% 125 grams of content resveratrols; 98% 120 grams of content procyanidins; 5% 130 grams of content astaxanthins; 20% 30 grams of content lycopenes; 20% 30 grams of content phylloxanthins and 6 grams of compositions of 10% content zeaxanthin.
The above; it is only the preferably specific embodiment of the present invention; these specific embodiment are all the different implementations based under general idea of the present invention; and protection scope of the present invention is not limited to this; anyly be familiar with those skilled in the art in the technical scope that the present invention discloses; the variation that can expect easily or replacement, within all should being encompassed in protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain of claims.
Claims (3)
1. one kind of multiple micronutrient element health product, is characterized in that, by weight by 200～500 grams of calcium carbonate; 100～200 grams of magnesium oxide; 15～30 grams of zinc lactate; 10～20 grams of sodium iron ethylenediaminetetraacetate; 0.5～2 gram of curpic carbonate; 3～8 grams of manganese carbonates; 0.5～2 gram of chromium picolinate; 0.2% 40～80 grams of content selenium yeast; 0.1～0.5 gram of sodium molybdate; 0.05～0.2 gram of cobalt carbonate; 50% 3～6 grams, content type vitamin A microcapsules powder; 15～40 grams of sodium ascorbaties; 50% 2～10 grams of content dimension dirt element E microcapsule powders; 0.25% 1～5 gram of content vitamin D microcapsule powder; Dimension dirt element B1:1.5～5 gram; Dimension dirt element B2:1.5～5 gram; Dimension dirt element B6:1.5～5 gram; Vitamin B12: 0.03～0.2 gram; 1.5～5 grams of nicotiamide; 1.5～5 grams of calcium pantothenates; 3～10 grams of biotin; 0.1～0.5 gram, folic acid; 50% 50～200 grams of content resveratrols; 98% 50～200 grams of procyanidins; 5% 50～200 grams of content astaxanthins; 20% 10～50 grams of content lycopenes; 20% 10～50 grams of content phylloxanthins and 2～10 grams of compositions of 10% content zeaxanthin.
2. lot of trace nutrient health product according to claim 1, is characterized in that, by weight by 210～490 grams of calcium carbonate; 110～190 grams of magnesium oxide; 16～29 grams of zinc lactate; 11～19 grams of sodium iron ethylenediaminetetraacetate; 0.6～1.9 gram of curpic carbonate; 4～7 grams of manganese carbonates; 0.6～1.9 gram of chromium picolinate; 0.2% 45～75 grams of content selenium yeast; 0.2～0.4 gram of sodium molybdate; 0.08～0.15 gram of cobalt carbonate; 50% 4～5 grams, content type vitamin A microcapsules powder; 20～35 grams, dimension dirt element C sodium; 50% 4～8 grams of content dimension dirt element E microcapsule powders; 0.25% 2～4 grams of content vitamin D microcapsule powders; Vitamin B1: 2～4 grams; Dimension dirt element B2:2～4 gram; Vitamin B6: 2～4 grams; Vitamin B12: 0.07～0.15 gram; 2～4 grams of nicotiamide; 2～4 grams of calcium pantothenates; 4～9 grams of dirt thing elements; 0.2～0.4 gram, folic acid; 50% 60～190 grams of content resveratrols; 98% 60～190 grams of content procyanidins; 5% 60～190 grams of content astaxanthins; 20% 20～40 grams of content lycopenes; 20% 20～40 grams of content phylloxanthins and 3～9 grams of compositions of 10% content zeaxanthin.
3. lot of trace nutrient health product according to claim 1, is characterized in that, by weight by 350 grams of calcium carbonate; 150 grams of magnesium oxide; 22 grams of zinc lactate; 15 grams of sodium iron ethylenediaminetetraacetate; 1.2 grams of curpic carbonate; 6 grams of manganese carbonates; 1 gram of chromium picolinate; 0.2% 60 grams of content selenium yeast; 0.3 gram of sodium molybdate; 0.1 gram of cobalt carbonate; 50% 4.5 grams of content dimension dirt element A microcapsule powders; 25 grams, dimension dirt element C sodium; 50% 6 grams of content dimension dirt element E microcapsule powders; 0.25% 3 grams of content vitamin D microcapsule powders; Vitamin B1: 3 grams; Dimension dirt element B2:3 gram; Dimension dirt element B6:3 gram; Dimension dirt element B12:0.11 gram; 3 grams of nicotiamide; 3 grams of calcium pantothenates; 7 grams of dirt thing elements; 0.3 gram, folic acid; 50% 125 grams of content resveratrols; 98% 120 grams of content procyanidins; 5% 130 grams of content astaxanthins; 20% 30 grams of content lycopenes; 20% 30 grams of content phylloxanthins and 6 grams of compositions of 10% content zeaxanthin.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310357259.7A CN103599137B (en) | 2013-08-16 | 2013-08-16 | One kind of multiple micronutrient element health product |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310357259.7A CN103599137B (en) | 2013-08-16 | 2013-08-16 | One kind of multiple micronutrient element health product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103599137A true CN103599137A (en) | 2014-02-26 |
| CN103599137B CN103599137B (en) | 2016-03-09 |
Family
ID=50117444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310357259.7A Expired - Fee Related CN103599137B (en) | 2013-08-16 | 2013-08-16 | One kind of multiple micronutrient element health product |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103599137B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105105147A (en) * | 2015-09-22 | 2015-12-02 | 哈尔滨宝德生物技术股份有限公司 | Nutrition and health care supplement rich in lutein and astaxanthin as well as preparation method |
| CN105410943A (en) * | 2015-11-30 | 2016-03-23 | 广州市富诺生物科技有限公司 | Compound vitamin tablets and preparation method thereof |
| CN105777496A (en) * | 2016-03-08 | 2016-07-20 | 陈爱华 | Method for extracting resveratrol from rhizoma polygoni cuspidate and rhizoma polygoni cuspidate healthcare product |
| US10206862B2 (en) | 2016-09-12 | 2019-02-19 | The Procter & Gamble Company | Supplement to support healthy hair, skin, and nails |
| CN111035012A (en) * | 2019-12-16 | 2020-04-21 | 青岛赛珥生物医学科技有限公司 | Antioxidant nutrition combination capsule and preparation method thereof |
| US11696593B2 (en) | 2018-08-24 | 2023-07-11 | Bioscience Formulators, LLC | Astaxanthin nutritional compositions and uses |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101675805A (en) * | 2008-09-16 | 2010-03-24 | 孙志刚 | ABC<ODAC> combined capsule optimal dietary supplement for middle-aged and elderly people |
| CN102232553A (en) * | 2010-05-06 | 2011-11-09 | 袁长铭 | Nutrient absorbing composition |
-
2013
- 2013-08-16 CN CN201310357259.7A patent/CN103599137B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101675805A (en) * | 2008-09-16 | 2010-03-24 | 孙志刚 | ABC<ODAC> combined capsule optimal dietary supplement for middle-aged and elderly people |
| CN102232553A (en) * | 2010-05-06 | 2011-11-09 | 袁长铭 | Nutrient absorbing composition |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105105147A (en) * | 2015-09-22 | 2015-12-02 | 哈尔滨宝德生物技术股份有限公司 | Nutrition and health care supplement rich in lutein and astaxanthin as well as preparation method |
| CN105410943A (en) * | 2015-11-30 | 2016-03-23 | 广州市富诺生物科技有限公司 | Compound vitamin tablets and preparation method thereof |
| CN105410943B (en) * | 2015-11-30 | 2018-05-15 | 广州富诺健康科技股份有限公司 | A kind of multivitamin tablet and preparation method thereof |
| CN105777496A (en) * | 2016-03-08 | 2016-07-20 | 陈爱华 | Method for extracting resveratrol from rhizoma polygoni cuspidate and rhizoma polygoni cuspidate healthcare product |
| US10206862B2 (en) | 2016-09-12 | 2019-02-19 | The Procter & Gamble Company | Supplement to support healthy hair, skin, and nails |
| US10632056B2 (en) | 2016-09-12 | 2020-04-28 | The Procter & Gamble Company | Supplement to support healthy hair, skin, and nails |
| US11696593B2 (en) | 2018-08-24 | 2023-07-11 | Bioscience Formulators, LLC | Astaxanthin nutritional compositions and uses |
| CN111035012A (en) * | 2019-12-16 | 2020-04-21 | 青岛赛珥生物医学科技有限公司 | Antioxidant nutrition combination capsule and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103599137B (en) | 2016-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Eliseeva et al. | Vitamin C (ascorbic acid)–description, benefits and where it is found | |
| CN102077936B (en) | Special sea dietary food for diabetics | |
| CN103599137B (en) | One kind of multiple micronutrient element health product | |
| CN102077940B (en) | Special dietary marine food for patients with coronary heart disease | |
| CN102077939B (en) | Marine special dietary food special for fat people | |
| CN102077938B (en) | Special marine dietary food for patients with liver deficiency | |
| CN103431392B (en) | Composite marine food for special dietary uses for diabetics | |
| CN102077934A (en) | Special dietary marine food for patients with high blood pressure | |
| RU2309751C1 (en) | Method for treating the disorders of mineral metabolism at arthritis, or osteochondrosis, or rickets, or arthrosis, or osteoporosis | |
| RU2665635C2 (en) | Multivitamin/mineral composition for controlling environmental stress effects; improving immunity and increasing activity, aiming at vitamin and mineral insufficiency with no negative side effects of mega-dosage food additive | |
| CN109475513A (en) | The energy composition of lifting motion ability | |
| CN105410930A (en) | Health-care product with weight-losing and body-slimming and nutrition-balancing functions and preparation method thereof | |
| CN102077943B (en) | Seafood for special dietary uses for hypomnesia patients | |
| CN110301647A (en) | The compound oligomeric peptide nutrient food of ground dragon protein | |
| CN102178718B (en) | Preparation used for treating diabetes mellitus and preventively treating heart cerebrovascular disease | |
| US20180169071A1 (en) | Nutritional supplement composition | |
| DE102014118772B4 (en) | Dietary supplement in capsule form containing Chinese medicinal mushrooms and their use | |
| CN101306056A (en) | Medicine composition for preventing the birth defect and improving the memory | |
| CN103404875A (en) | Complex ocean special-diet food eaten by patients with cardiovascular disease | |
| CN104106826B (en) | A kind of gadol beverage and preparation method thereof | |
| CN105248944A (en) | Production method of potassium-rich and carotene-rich eggs | |
| CN102077941B (en) | Special dietary seafood special for climacteric women | |
| CN101683164A (en) | Method for manufacturing radiation resistant health drink | |
| CN105831730A (en) | Krill oil composite special dietary food for reducing hypertension, hyperglycemia and hyperlipidemia | |
| CN105031248A (en) | Health care product which contains Se-enriched cordyceps and is capable of assisting in blood sugar level regulation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160309 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |